Sonnet Biotherapeutics Holdings Inc expected to post a loss of 14  cents a share - Earnings Preview

Sonnet Biotherapeutics Holdings

12/08/2022 11:32

* Sonnet Biotherapeutics Holdings Inc  SONN.OQ   SONN.O  is
expected to report results on August 15 (estimated).
    * The Princeton New Jersey-based  company is expected to
report
revenue of $50 thousand, according to the mean estimate from 2
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Sonnet
Biotherapeutics
Holdings Inc is for a loss of 14 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sonnet
Biotherapeutics Holdings Inc is $2.25​, above​ its last closing
price of $0.29. ​​​

This summary was machine generated August 12 at 10:32 GMT.  All
figures in US dollars  unless otherwise stated